Pure Global AI
ANVISA RDC

RDC 687/2022

GMP Inspection and Certification Programs for Medical Devices
BrazilANVISAGMP/QMSEffective June 1, 2022
Official source linked
What this code is

RDC 687/2022 is ANVISA Collegiate Board Resolution 687/2022. A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022).

Instrument
RDC
Full name
Resolução da Diretoria Colegiada
Category
GMP/QMS
Source links
Authority source
English
Open the issuing-authority text
ANVISA-hosted English text; confirm legal effect against the current official Portuguese publication.
Readable HTML
17 articles · 2 language versions
Read the full text →
Direct citations can link to an article, for example /data/regulations/brazil/rdc-687-2022.en.html#art-1.
Dates
Published
May 18, 2022
Effective
June 1, 2022
Readable full text

Open a language version

Each version has stable article anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

English full text17 articles · English — ANVISA translationRead HTML →Portuguese full text17 articles · Portuguese — official textRead HTML →
About this regulation

GMP Inspection and Certification Programs for Medical Devices

Inspection programs and criteria for granting or renewing Good Manufacturing Practices certificates for medical device manufacturers, including use of MDSAP audit reports and regulatory-authority inspection information.

A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022). Always confirm the current consolidated text and transition provisions with the official source before filing.

Verified